Logo (Actavis) 323 (Morphine Sulfate Extended-Release 100 mg)
Pill with imprint Logo (Actavis) 323 is Red, Round and has been identified as Morphine Sulfate Extended-Release 100 mg. It is supplied by Actavis Pharma, Inc.
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 100 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for Logo (Actavis) 323
Morphine Sulfate Extended-Release
- Imprint
- Logo (Actavis) 323
- Strength
- 100 mg
- Color
- Red
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00228-4323
- Inactive Ingredients
-
lactose anhydrous,
magnesium stearate,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
polyethylene glycol,
cetostearyl alcohol
Note: Inactive ingredients may vary.
More about morphine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (352)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: narcotic analgesics
- Latest FDA Alerts (11)
Patient resources
- Drug Information
- Morphine injection
- Morphine (Advanced Reading)
- Morphine Epidural (Advanced Reading)
- Morphine Injection (Advanced Reading)
Other brands
MS Contin, Roxanol, Kadian, Astramorph PF, ... +10 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.